Maxcyte, Inc.
MXCT· Nasdaq
Released May 7, 2025, after the close
10-Q filed May 8, 2025, 38 days after period end · 0001558370-25-007005
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$10.26M | -$9.53M | -$10.88M | -$4.07M |
| EPS Diluted | -$0.10 | — | -$0.11 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Maxcyte, Inc. · CIK 1287098 · Engraved from SEC EDGAR